StemSight develops off-the-shelf regenerative cell therapies for corneal blindness. Our expertise is in the combination of iPS-derived cells with functional biomaterials - for FASTER tissue regeneration, SAFER cell therapies and EASIER cell delivery.
Company Details
- Employees
- 20
- Founded
- -
- Address
- Tampere, Fi
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.stemsight.fi
- HQ
- Tampere
Stemsight Questions
Stemsight's website is http://www.stemsight.fi
Stemsight's LinkedIn profile is https://fi.linkedin.com/company/stemsight
Stemsight has
20 employees.
View email and phone details for 20
employees at Stemsight.
Stemsight's industry is
Biotechnology Research
Stemsight's top competitors are
Biomendex,
Lifeglue Technologies,
Newleos Therapeutics,
Arctic Therapeutics,
Latent Labs,
Genprex, Inc.,
Smartcella Holding Ab,
Oculis,
Harmonic Discovery,
Precisionphage.
Stemsight's categories are Biotechnology Research
Stemsight's founding year is 2021
